We only have this paper's title and publication details.
Read it at the sourceCase report demonstrates continued remission with decitabine monotherapy in post-transplant relapsed TP53 multi-hit AML, highlighting a salvage option for high-risk elderly patients.
No takes yet. Share an insight, caveat, or question.
List et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: